These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 618993)

  • 21. Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin.
    Brown CF; Osmond DH
    Clin Sci (Lond); 1984 May; 66(5):533-9. PubMed ID: 6368100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of prekallikrein and kallikrein in pregnancy and labor.
    Sayama S; Kashiwagi H; Ogawa T; Terada K; Soma H; Kato M
    Int J Biol Res Pregnancy; 1981; 2(2):90-4. PubMed ID: 6916725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The plasma contact system in atopic asthma.
    Lasser EC; Lang JH; Curd JG; Cochrane CG; Lyon SG; Howard MM; Hamblin AE; Revak SD
    J Allergy Clin Immunol; 1983 Jul; 72(1):83-8. PubMed ID: 6189880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
    Harpel PC; Lewin MF; Kaplan AP
    J Biol Chem; 1985 Apr; 260(7):4257-63. PubMed ID: 2579948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
    Donaldson VH; Harrison RA
    Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.
    Tankersley DL; Alving BM; Finlayson JS
    Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
    Claeson G; Friberger P; Knös M; Eriksson E
    Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of factor XII and prekallikrein with cholesterol sulfate.
    Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y
    Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activation of the kallikrein-kinin system by intravenous administration of ionic and non-ionic radiographic contrast media].
    Hoffmeister HM; Fuhrer G; Abels GA; Pirschel J; Heller W
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1138-41. PubMed ID: 3260554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.